US Patent Issued to INTEGREON GLOBAL on June 16 for "Protein constructs of moloney murine leukemia virus reverse transcriptase (MMLV-RT)" (Canadian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,401, issued on June 16, was assigned to INTEGREON GLOBAL INC. (Short Hills, N.J.).

"Protein constructs of moloney murine leukemia virus reverse transcriptase (MMLV-RT)" was invented by Thomas Martin Thorne Schmeing (Montreal, Canada) and Michael John Tarry (Saint Laurent, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are protein constructs of Moloney murine leukemia virus reverse transcriptase (MMLV-RT). In one embodiment the protein construct comprises a Moloney murine leukemia virus reverse transcriptase (MMLV) mature protein sequence; and an expression enhancement sequence at the N-terminus of said MMLV mature protein sequence. ...